Literature DB >> 3972843

Interactions between protein 4.1 and band 3. An alternative binding site for an element of the membrane skeleton.

G R Pasternack, R A Anderson, T L Leto, V T Marchesi.   

Abstract

Protein 4.1 from human erythrocytes formed a complex with band 3 in inside-out erythrocyte membrane vesicles and with soluble peptides derived from the cytoplasmic domain of band 3. Protein 4.1 labeled metabolically with 32P bound saturably to vesicles depleted of endogenous protein 4.1. The soluble cytoplasmic domain of band 3 (43K) competitively displaced approximately 60% of bound 32P-protein 4.1 from reconstituted membrane vesicles. Pretreatment of vesicles with anti-43K similarly inhibited the rebinding of protein 4.1. In solution, 125I-43K formed a complex with protein 4.1 that saturated at 1:1 stoichiometry and migrated as a discrete band when analyzed by nondenaturing polyacrylamide gel electrophoresis. In rate-zonal sedimentation in isotonic salt solutions, protein 4.1 and 43K sedimented as a sharp peak at 4.4 S. In experiments aimed at exploring the role of the protein 4.1-band 3 interaction in the organization of the membrane skeleton, the effect of spectrin was investigated. Spectrin and protein 4.1 formed a complex which co-sedimented in sucrose gradients, but the addition of 43K to preformed spectrin-protein 4.1 complexes resulted in disruption of the complex and co-sedimentation of most of the protein 4.1 with 43K. These results suggest that protein 4.1 can associate with band 3 in the erythrocyte membrane and that this association may modulate the attachment of the membrane skeleton to the membrane.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3972843

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  A novel neuron-enriched homolog of the erythrocyte membrane cytoskeletal protein 4.1.

Authors:  L D Walensky; S Blackshaw; D Liao; C C Watkins; H U Weier; M Parra; R L Huganir; J G Conboy; N Mohandas; S H Snyder
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

2.  Regulation of AMPA receptor GluR1 subunit surface expression by a 4. 1N-linked actin cytoskeletal association.

Authors:  L Shen; F Liang; L D Walensky; R L Huganir
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

3.  A nonerythroid isoform of protein 4.1R interacts with components of the contractile apparatus in skeletal myofibers.

Authors:  A Kontrogianni-Konstantopoulos; S C Huang; E J Benz
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

4.  Deciphering the nuclear import pathway for the cytoskeletal red cell protein 4.1R.

Authors:  P Gascard; W Nunomura; G Lee; L D Walensky; S W Krauss; Y Takakuwa; J A Chasis; N Mohandas; J G Conboy
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

5.  Homozygous 4.1(-) hereditary elliptocytosis associated with a point mutation in the downstream initiation codon of protein 4.1 gene.

Authors:  N Dalla Venezia; F Gilsanz; N Alloisio; M T Ducluzeau; E J Benz; J Delaunay
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

Review 6.  The spectrin-ankyrin-4.1-adducin membrane skeleton: adapting eukaryotic cells to the demands of animal life.

Authors:  Anthony J Baines
Journal:  Protoplasma       Date:  2010-07-29       Impact factor: 3.356

Review 7.  Oxygen-linked modulation of erythrocyte metabolism: state of the art.

Authors:  Massimo Castagnola; Irene Messana; Maria Teresa Sanna; Bruno Giardina
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

8.  Characterization and cytoskeletal association of a major cell surface glycoprotein, GP 140, in human neutrophils.

Authors:  S J Suchard; L A Boxer
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

9.  Identification of adducin-binding residues on the cytoplasmic domain of erythrocyte membrane protein, band 3.

Authors:  Taina Franco; Haiyan Chu; Philip S Low
Journal:  Biochem J       Date:  2016-07-19       Impact factor: 3.857

10.  Band 3 antagonists, p-azidobenzylphlorizin and DIDS, mediate erythrocyte shape and flexibility changes as characterized by digital image morphometry and microfiltration.

Authors:  D M Hoefner; M E Blank; B M Davis; D F Diedrich
Journal:  J Membr Biol       Date:  1994-07       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.